Pratibha Kumari

Pratibha Kumari

Auto-generated profile, based on publicly available information

Pratibha Kumari

Department of Chemistry and Applied Biosciences, Laboratory of Physical Chemistry, ETH Zurich, 8093 Zurich, Switzerland

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2019 in eLife
Verified
Journal Article
Open access
RGRicardo Guerrero-Ferreira
Ricardo Guerrero-Ferreira
NTNicholas Taylor
Nicholas Taylor
AAAna Andreea Arteni
Ana Andreea Arteni
PKPratibha Kumari
Pratibha Kumari
DMDaniel Mona
Daniel Mona
HSHenning Stahlberg
Henning Stahlberg
Intracellular inclusions rich in alpha-synuclein are a hallmark of several neuropathological diseases including Parkinson’s disease (PD). Previously, we reported the structure of alpha-synuclein fibrils (residues 1–121), composed of two protofibrils that are connected via a densely-packed interface formed by residues 50–57 (Guerrero-Ferreira, eLife 218;7:e36402). We here report two new polymorphic atomic structures of alpha-synuclein fibrils termed polymorphs 2a and 2b, at 3.0 Å and 3.4 Å resolution, respectively. These polymorphs show a radically different structure compared to previously reported polymorphs. The new structures have a 10 nm fibril diameter and are composed of two protofilaments which interact via intermolecular salt-bridges between amino acids K45, E57 (polymorph 2a) or E46 (polymorph 2b). The non-amyloid component (NAC) region of alpha-synuclein is fully buried by previously non-described interactions with the N-terminus. A hydrophobic cleft, the location of familial PD mutation sites, and the nature of the protofilament interface now invite to formulate hypotheses about fibril formation, growth and stability.

4 December 2019 in Nature
Verified
Journal Article
Closed access
PDF file
BBBjörn Burmann
Björn Burmann
JGJuan A. Gerez
Juan A. Gerez
IMIrena Matečko-Burmann
Irena Matečko-Burmann
SCSilvia Campioni
Silvia Campioni
PKPratibha Kumari
Pratibha Kumari
SHSebastian Hiller
Sebastian Hiller

9 March 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
PKPratibha Kumari
Pratibha Kumari
DGDhiman Ghosh
Dhiman Ghosh
AVAgathe Vanas
Agathe Vanas
YFYanick Fleischmann
Yanick Fleischmann
TWThomas Wiegand
Thomas Wiegand
CECédric Eichmann
Cédric Eichmann
Significance: The characteristic feature of Parkinson’s disease is the deposition of α-synuclein into insoluble amyloid fibrils. The so-called secondary nucleation mechanism appears to be key for the aggregation kinetics, because binding of monomers on the fibril surface can autocatalytically induce new amyloid seeds. We show by nuclear magnetic and electron paramagnetic resonance spectroscopy that α-synuclein monomer–fibril binding is primarily mediated by transient electrostatic interactions. These intermolecular contacts result in an unfolding of the loosely packed α-synuclein structures and expose the otherwise protected aggregation-prone non-amyloid-β component of the protein. Our data demonstrate that intramolecular unfolding of α-synuclein is a prerequisite for protein aggregation that leads to rapid multiplication of α-synuclein amyloid fibrils via the secondary nucleation process.

1 October 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
HKHarish Kumar
Harish Kumar
JSJogender Singh
Jogender Singh
PKPratibha Kumari
Pratibha Kumari
JUJayant B. Udgaonkar
Jayant B. Udgaonkar
The transition of intrinsically disordered, monomeric α-synuclein into β-sheet–rich oligomers and fibrils is associated with multiple neurodegenerative diseases. Fibrillar aggregates possessing distinct structures that differ in toxicity have been observed in different pathological phenotypes. Understanding the mechanism of the formation of various fibril polymorphs with differing cytotoxic effects is essential for determining how the aggregation reaction could be modulated to favor nontoxic fibrils over toxic fibrils. In this study, two morphologically different α-synuclein fibrils, one helical and the other ribbon-like, are shown to form together. Surprisingly, a widely used small molecule for probing aggregation reactions, thioflavin T (ThT), was found to tune the structural heterogeneity found in the fibrils. The ribbon-like fibrils formed in the presence of ThT were found to have a longer structural core than the helical fibrils formed in the absence of ThT. The ribbon-like fibrils are also more toxic to cells. By facilitating the formation of ribbon-like fibrils over helical fibrils, ThT reduced the extent of fibril polymorphism. This study highlights the role of a small molecule such as ThT in selectively favoring the formation of a specific type of fibril by binding to aggregates formed early on one of multiple pathways, thereby altering the structural core and external morphology of the fibrils formed.

18 January 2017 in FEBS Letters
Verified
Journal Article
Closed access
PDF file
CECédric Eichmann
Cédric Eichmann
PKPratibha Kumari
Pratibha Kumari
Roland RiekRoland Riek
Roland Riek

10 October 2018 in Journal of Biomolecular NMR
Verified
Journal Article
Closed access
PDF file
PKPratibha Kumari
Pratibha Kumari
LFLukas Frey
Lukas Frey
ASAlexander Sobol
Alexander Sobol
NLNils-Alexander Lakomek
Nils-Alexander Lakomek
Roland RiekRoland Riek
Roland Riek